Newly-Public New Haven Biotech Assembles Downtown Portfolio
With a May 8 sale, New Haven-based Biohaven Pharmaceuticals now controls three properties on Church Street in the city’s downtown: its current home plus neighboring parcels on either side.
As Big Markets Pull Back, Elm City Lab Projects Advance
Newly-approved plans for office and medical research space point to potential expansion of New Haven’s life science ecosystem at a time when developers in other cities are having trouble filling space in many of the nation’s largest biotech clusters.
New Haven OKs 47K SF Bioscience Building
Life science real estate may be struggling nation-wide thanks to a slowdown in new funding for biotech startups tied to high interest rates, but that’s not stopping one New Haven developer.
State Biotech Trade Group Takes Space in New Haven Lab Tower
The trade group for Connecticut life science companies is moving into the state’s newest biotech building and adding a prominent developer to its board.
PHOTOS: Inside New Haven Office-to-Lab Conversion
A former office building in downtown New Haven being repositioned to lab uses now has a pair of tenants ensconced on two floors, and hopes to add more soon.
New Haven Named in Top 20 Biotech Markets
A new report from commercial real estate brokerage CBRE put New Haven in the top 20 markets for life science talent nation-wide.
First Life Science Lease Inked at New Haven’s Winchester Works
A lab-focused renovation north of downtown New Haven is beginning to pay off for the joint venture that acquired the property in 2019 with the signing of its first major biotech tenant.
